Source link : https://www.newshealth.biz/health-news/eating-disorders-after-glp-1s-tirzepatide-for-heart-failure-soda-taxes-and-bmi/
Weight-loss drugs like tirzepatide (Zepbound) and semaglutide (Wegovy) may trigger eating disorders in certain patients, doctors warned. (NBC News) In a placebo-controlled phase III trial, tirzepatide reduced the risk of heart failure outcomes by 38% for adults with obesity and heart failure with preserved ejection fraction, Eli Lilly announced. Bayer submitted a new drug application […]
Author : News Health
Publish date : 2024-08-06 17:51:32
Copyright for syndicated content belongs to the linked Source.
inHealth